Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.7778 |
Intermediate Similarity |
NPD7130 |
Phase 3 |
0.7615 |
Intermediate Similarity |
NPD5339 |
Clinical (unspecified phase) |
0.7541 |
Intermediate Similarity |
NPD480 |
Approved |
0.7521 |
Intermediate Similarity |
NPD2583 |
Phase 2 |
0.7481 |
Intermediate Similarity |
NPD3604 |
Clinical (unspecified phase) |
0.7462 |
Intermediate Similarity |
NPD2031 |
Discontinued |
0.7462 |
Intermediate Similarity |
NPD6792 |
Phase 3 |
0.7419 |
Intermediate Similarity |
NPD3551 |
Approved |
0.7385 |
Intermediate Similarity |
NPD4677 |
Discontinued |
0.7323 |
Intermediate Similarity |
NPD6343 |
Approved |
0.7323 |
Intermediate Similarity |
NPD6345 |
Approved |
0.7308 |
Intermediate Similarity |
NPD2584 |
Suspended |
0.7305 |
Intermediate Similarity |
NPD1968 |
Approved |
0.7305 |
Intermediate Similarity |
NPD1967 |
Approved |
0.728 |
Intermediate Similarity |
NPD5631 |
Phase 3 |
0.7273 |
Intermediate Similarity |
NPD3029 |
Clinical (unspecified phase) |
0.7259 |
Intermediate Similarity |
NPD5581 |
Approved |
0.7234 |
Intermediate Similarity |
NPD6860 |
Clinical (unspecified phase) |
0.7218 |
Intermediate Similarity |
NPD3608 |
Clinical (unspecified phase) |
0.7214 |
Intermediate Similarity |
NPD7720 |
Phase 2 |
0.7209 |
Intermediate Similarity |
NPD6806 |
Phase 1 |
0.7197 |
Intermediate Similarity |
NPD3125 |
Approved |
0.7185 |
Intermediate Similarity |
NPD6919 |
Clinical (unspecified phase) |
0.7165 |
Intermediate Similarity |
NPD3123 |
Discovery |
0.7165 |
Intermediate Similarity |
NPD7679 |
Phase 2 |
0.7164 |
Intermediate Similarity |
NPD3626 |
Phase 3 |
0.7154 |
Intermediate Similarity |
NPD3581 |
Discontinued |
0.7143 |
Intermediate Similarity |
NPD6897 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD4803 |
Discontinued |
0.7133 |
Intermediate Similarity |
NPD6017 |
Discontinued |
0.7132 |
Intermediate Similarity |
NPD4504 |
Clinical (unspecified phase) |
0.7123 |
Intermediate Similarity |
NPD7131 |
Phase 3 |
0.7109 |
Intermediate Similarity |
NPD5991 |
Approved |
0.7109 |
Intermediate Similarity |
NPD3806 |
Clinical (unspecified phase) |
0.7109 |
Intermediate Similarity |
NPD5990 |
Approved |
0.7099 |
Intermediate Similarity |
NPD4706 |
Clinical (unspecified phase) |
0.7083 |
Intermediate Similarity |
NPD5103 |
Approved |
0.7071 |
Intermediate Similarity |
NPD5301 |
Clinical (unspecified phase) |
0.7063 |
Intermediate Similarity |
NPD5181 |
Approved |
0.7063 |
Intermediate Similarity |
NPD5180 |
Approved |
0.7063 |
Intermediate Similarity |
NPD5179 |
Approved |
0.7063 |
Intermediate Similarity |
NPD5481 |
Discontinued |
0.7045 |
Intermediate Similarity |
NPD3071 |
Approved |
0.7045 |
Intermediate Similarity |
NPD3073 |
Approved |
0.7045 |
Intermediate Similarity |
NPD3072 |
Approved |
0.704 |
Intermediate Similarity |
NPD4991 |
Discontinued |
0.704 |
Intermediate Similarity |
NPD753 |
Approved |
0.7031 |
Intermediate Similarity |
NPD1344 |
Phase 2 |
0.7031 |
Intermediate Similarity |
NPD4431 |
Clinical (unspecified phase) |
0.7029 |
Intermediate Similarity |
NPD4791 |
Clinical (unspecified phase) |
0.7029 |
Intermediate Similarity |
NPD6623 |
Phase 3 |
0.7015 |
Intermediate Similarity |
NPD2585 |
Clinical (unspecified phase) |
0.7014 |
Intermediate Similarity |
NPD6552 |
Clinical (unspecified phase) |
0.7014 |
Intermediate Similarity |
NPD8323 |
Discontinued |
0.7014 |
Intermediate Similarity |
NPD7602 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD6024 |
Approved |
0.7 |
Intermediate Similarity |
NPD6294 |
Approved |
0.7 |
Intermediate Similarity |
NPD6027 |
Approved |
0.7 |
Intermediate Similarity |
NPD6295 |
Approved |
0.6986 |
Remote Similarity |
NPD4432 |
Discontinued |
0.6985 |
Remote Similarity |
NPD4125 |
Approved |
0.6985 |
Remote Similarity |
NPD5263 |
Approved |
0.6978 |
Remote Similarity |
NPD7113 |
Clinical (unspecified phase) |
0.6978 |
Remote Similarity |
NPD3908 |
Approved |
0.6972 |
Remote Similarity |
NPD3434 |
Clinical (unspecified phase) |
0.697 |
Remote Similarity |
NPD4761 |
Approved |
0.697 |
Remote Similarity |
NPD4762 |
Approved |
0.6967 |
Remote Similarity |
NPD999 |
Phase 2 |
0.6964 |
Remote Similarity |
NPD5252 |
Clinical (unspecified phase) |
0.696 |
Remote Similarity |
NPD3642 |
Approved |
0.696 |
Remote Similarity |
NPD3644 |
Approved |
0.696 |
Remote Similarity |
NPD3643 |
Approved |
0.695 |
Remote Similarity |
NPD6655 |
Clinical (unspecified phase) |
0.6949 |
Remote Similarity |
NPD4655 |
Approved |
0.6949 |
Remote Similarity |
NPD4657 |
Approved |
0.694 |
Remote Similarity |
NPD5577 |
Clinical (unspecified phase) |
0.694 |
Remote Similarity |
NPD5578 |
Approved |
0.6934 |
Remote Similarity |
NPD4497 |
Clinical (unspecified phase) |
0.6929 |
Remote Similarity |
NPD8172 |
Phase 2 |
0.6929 |
Remote Similarity |
NPD8173 |
Phase 2 |
0.6929 |
Remote Similarity |
NPD4782 |
Clinical (unspecified phase) |
0.6918 |
Remote Similarity |
NPD2014 |
Approved |
0.6918 |
Remote Similarity |
NPD2016 |
Approved |
0.6918 |
Remote Similarity |
NPD2013 |
Approved |
0.6912 |
Remote Similarity |
NPD1781 |
Discontinued |
0.6906 |
Remote Similarity |
NPD5272 |
Discontinued |
0.6884 |
Remote Similarity |
NPD1329 |
Clinical (unspecified phase) |
0.6884 |
Remote Similarity |
NPD1330 |
Phase 2 |
0.688 |
Remote Similarity |
NPD4063 |
Clinical (unspecified phase) |
0.6879 |
Remote Similarity |
NPD6901 |
Phase 3 |
0.6875 |
Remote Similarity |
NPD2508 |
Discontinued |
0.6875 |
Remote Similarity |
NPD5024 |
Approved |
0.6861 |
Remote Similarity |
NPD7979 |
Clinical (unspecified phase) |
0.686 |
Remote Similarity |
NPD6588 |
Clinical (unspecified phase) |
0.6857 |
Remote Similarity |
NPD8643 |
Discontinued |
0.6842 |
Remote Similarity |
NPD1948 |
Approved |
0.6842 |
Remote Similarity |
NPD3624 |
Phase 2 |
0.6835 |
Remote Similarity |
NPD7086 |
Phase 2 |
0.6835 |
Remote Similarity |
NPD3561 |
Clinical (unspecified phase) |
0.6835 |
Remote Similarity |
NPD941 |
Approved |
0.6831 |
Remote Similarity |
NPD7728 |
Clinical (unspecified phase) |
0.6824 |
Remote Similarity |
NPD3822 |
Approved |
0.6824 |
Remote Similarity |
NPD3820 |
Approved |
0.6824 |
Remote Similarity |
NPD3821 |
Clinical (unspecified phase) |
0.6815 |
Remote Similarity |
NPD2634 |
Clinical (unspecified phase) |
0.6809 |
Remote Similarity |
NPD6817 |
Clinical (unspecified phase) |
0.6807 |
Remote Similarity |
NPD1099 |
Approved |
0.6807 |
Remote Similarity |
NPD1100 |
Approved |
0.6806 |
Remote Similarity |
NPD5341 |
Clinical (unspecified phase) |
0.6803 |
Remote Similarity |
NPD6088 |
Approved |
0.6803 |
Remote Similarity |
NPD3282 |
Phase 1 |
0.6803 |
Remote Similarity |
NPD3283 |
Phase 3 |
0.6794 |
Remote Similarity |
NPD998 |
Approved |
0.6791 |
Remote Similarity |
NPD5108 |
Clinical (unspecified phase) |
0.6788 |
Remote Similarity |
NPD4177 |
Approved |
0.6788 |
Remote Similarity |
NPD3040 |
Approved |
0.6788 |
Remote Similarity |
NPD4175 |
Approved |
0.678 |
Remote Similarity |
NPD4094 |
Approved |
0.6777 |
Remote Similarity |
NPD5630 |
Phase 1 |
0.6767 |
Remote Similarity |
NPD5187 |
Clinical (unspecified phase) |
0.6767 |
Remote Similarity |
NPD1947 |
Approved |
0.6763 |
Remote Similarity |
NPD3632 |
Clinical (unspecified phase) |
0.6761 |
Remote Similarity |
NPD4077 |
Clinical (unspecified phase) |
0.6759 |
Remote Similarity |
NPD4464 |
Clinical (unspecified phase) |
0.6757 |
Remote Similarity |
NPD4942 |
Approved |
0.6757 |
Remote Similarity |
NPD4939 |
Clinical (unspecified phase) |
0.6757 |
Remote Similarity |
NPD5941 |
Approved |
0.6757 |
Remote Similarity |
NPD5942 |
Approved |
0.675 |
Remote Similarity |
NPD466 |
Approved |
0.6744 |
Remote Similarity |
NPD2543 |
Discontinued |
0.6744 |
Remote Similarity |
NPD3867 |
Phase 2 |
0.6739 |
Remote Similarity |
NPD5131 |
Approved |
0.6739 |
Remote Similarity |
NPD4676 |
Approved |
0.6735 |
Remote Similarity |
NPD8290 |
Clinical (unspecified phase) |
0.6732 |
Remote Similarity |
NPD7599 |
Phase 2 |
0.6716 |
Remote Similarity |
NPD4775 |
Clinical (unspecified phase) |
0.6715 |
Remote Similarity |
NPD4151 |
Approved |
0.6715 |
Remote Similarity |
NPD5993 |
Phase 1 |
0.6714 |
Remote Similarity |
NPD6740 |
Clinical (unspecified phase) |
0.6694 |
Remote Similarity |
NPD1767 |
Approved |
0.6694 |
Remote Similarity |
NPD1761 |
Approved |
0.6694 |
Remote Similarity |
NPD1766 |
Approved |
0.6694 |
Remote Similarity |
NPD1765 |
Approved |
0.6694 |
Remote Similarity |
NPD742 |
Approved |
0.6694 |
Remote Similarity |
NPD1763 |
Approved |
0.6693 |
Remote Similarity |
NPD4254 |
Approved |
0.6693 |
Remote Similarity |
NPD4253 |
Approved |
0.6691 |
Remote Similarity |
NPD6330 |
Clinical (unspecified phase) |
0.6691 |
Remote Similarity |
NPD5136 |
Clinical (unspecified phase) |
0.669 |
Remote Similarity |
NPD8125 |
Discontinued |
0.669 |
Remote Similarity |
NPD6073 |
Approved |
0.6688 |
Remote Similarity |
NPD7600 |
Phase 2 |
0.6667 |
Remote Similarity |
NPD2997 |
Approved |
0.6667 |
Remote Similarity |
NPD23 |
Approved |
0.6667 |
Remote Similarity |
NPD7735 |
Clinical (unspecified phase) |
0.6667 |
Remote Similarity |
NPD7450 |
Phase 2 |
0.6667 |
Remote Similarity |
NPD3598 |
Phase 3 |
0.6667 |
Remote Similarity |
NPD3000 |
Approved |
0.6667 |
Remote Similarity |
NPD2998 |
Approved |
0.6667 |
Remote Similarity |
NPD6408 |
Phase 1 |
0.6645 |
Remote Similarity |
NPD2891 |
Approved |
0.6643 |
Remote Similarity |
NPD6358 |
Phase 2 |
0.6642 |
Remote Similarity |
NPD2840 |
Approved |
0.6622 |
Remote Similarity |
NPD6884 |
Clinical (unspecified phase) |
0.662 |
Remote Similarity |
NPD3577 |
Discontinued |
0.662 |
Remote Similarity |
NPD2791 |
Discontinued |
0.6619 |
Remote Similarity |
NPD6359 |
Clinical (unspecified phase) |
0.6619 |
Remote Similarity |
NPD5202 |
Clinical (unspecified phase) |
0.6618 |
Remote Similarity |
NPD3550 |
Clinical (unspecified phase) |
0.6618 |
Remote Similarity |
NPD5157 |
Phase 1 |
0.6618 |
Remote Similarity |
NPD3549 |
Approved |
0.6618 |
Remote Similarity |
NPD5158 |
Clinical (unspecified phase) |
0.6618 |
Remote Similarity |
NPD5159 |
Phase 2 |
0.6618 |
Remote Similarity |
NPD3547 |
Approved |
0.66 |
Remote Similarity |
NPD6144 |
Discontinued |
0.66 |
Remote Similarity |
NPD5748 |
Phase 2 |
0.66 |
Remote Similarity |
NPD7613 |
Discontinued |
0.6597 |
Remote Similarity |
NPD7142 |
Discontinued |
0.6597 |
Remote Similarity |
NPD7254 |
Discontinued |
0.6593 |
Remote Similarity |
NPD7462 |
Clinical (unspecified phase) |
0.6587 |
Remote Similarity |
NPD6038 |
Clinical (unspecified phase) |
0.6585 |
Remote Similarity |
NPD813 |
Approved |
0.6583 |
Remote Similarity |
NPD2895 |
Discontinued |
0.6583 |
Remote Similarity |
NPD2507 |
Clinical (unspecified phase) |
0.6577 |
Remote Similarity |
NPD1582 |
Approved |
0.6577 |
Remote Similarity |
NPD1581 |
Approved |
0.6573 |
Remote Similarity |
NPD7192 |
Discontinued |
0.6571 |
Remote Similarity |
NPD2754 |
Discontinued |
0.6569 |
Remote Similarity |
NPD1482 |
Clinical (unspecified phase) |
0.6569 |
Remote Similarity |
NPD6325 |
Discontinued |
0.6569 |
Remote Similarity |
NPD2962 |
Approved |
0.6569 |
Remote Similarity |
NPD2961 |
Approved |
0.6567 |
Remote Similarity |
NPD4733 |
Approved |
0.6567 |
Remote Similarity |
NPD3064 |
Clinical (unspecified phase) |
0.6565 |
Remote Similarity |
NPD1323 |
Discontinued |
0.656 |
Remote Similarity |
NPD2197 |
Approved |
0.656 |
Remote Similarity |
NPD2192 |
Approved |
0.656 |
Remote Similarity |
NPD1018 |
Approved |
0.6558 |
Remote Similarity |
NPD7011 |
Discontinued |
0.6556
|
Remote Similarity |
NPD6575 |
Clinical (unspecified phase) |